Clinical Trial Update: Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating denosumab and cinacalcet for primary hyperparathyroidism; study completed with posted results in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism
• Parathyroid Adenoma
• Parathyroid Hyperplasia

Drugs mentioned

• Denosumab (denosumab)
• cinacalcet (cinacalcet hydrochloride)

Snippet

Sponsor: Peter Vestergaard | Conditions: Primary Hyperparathyroidism, Parathyroid Adenoma | Phase 3 | Status: COMPLETED | Results posted: 2021-05-25